Urinary 8-isoprostane as a biomarker for oxidative stress. A systematic review and meta-analysis.


Journal

Toxicology letters
ISSN: 1879-3169
Titre abrégé: Toxicol Lett
Pays: Netherlands
ID NLM: 7709027

Informations de publication

Date de publication:
01 Aug 2020
Historique:
received: 01 11 2019
revised: 31 03 2020
accepted: 08 04 2020
pubmed: 23 4 2020
medline: 2 6 2020
entrez: 23 4 2020
Statut: ppublish

Résumé

Oxidative stress is defined as an imbalance between the production and elimination of reactive oxygen species (ROS) are associated with various inflammation-related human disease. ROS can oxidize lipids, which subsequently undergo fragmentation to produce F2-isoprostanes (F2-IsoPs). Eight-isoprostane is one of the most extensively studied F2-IsoPs and the most commonly used biomarker for the assessment of oxidative stress in human studies. This urinary biomarker is quantified using either chemical or immunological techniques. A "physiological" range for 8-isoprostanes is needed to use this biomarker as a measure of excess oxidative stress originating from occupational exposures. However, ranges reported in the literature are inconsistent. We designed a standardized protocol of a systematic review and meta-analysis to assess baseline values for 8-isoprostane concentrations in urine of healthy adults and identify determinants of their inter- and intra-individual variability. We searched PubMed from journal inception and up to April 2019, and screened articles for studies containing F2-IsoPs concentrations in urine for healthy adult participants. We grouped studies in three biomarker groups: "8-isoprostane", "Isoprostanes" "15- F2t-Isoprostane". We computed geometric mean (GM) and geometric standard deviation (GSD) as the basis for the meta-analysis. Of the initial 1849 articles retrieved, 63 studies were included and 107 subgroups within these study populations were identified. We stratified the subgroups analyzed with the chemical methods by body mass index (BMI) reported. We provide pooled GM values for urinary 8-isoprostane concentrations in healthy adults, separately for chemical and immunological analysis in this review. The interquartile range (IQR) in subgroups with a mean BMI below 25 measured using chemical methods was 0.18 to 0.40 μg/g creatinine. We show that there is a significant positive association between BMI and urinary 8-isoprostane concentrations. We recommend adjusting urinary 8-isoprostane concentrations in spot urine with creatinine, quantifying 8-isoprostane with chemical analytical methods, and reporting results as median and quartiles. This will help in comparing results across studies.

Identifiants

pubmed: 32320775
pii: S0378-4274(20)30117-X
doi: 10.1016/j.toxlet.2020.04.006
pii:
doi:

Substances chimiques

Biomarkers 0
Xenobiotics 0
8-epi-prostaglandin F2alpha 27415-26-5
Dinoprost B7IN85G1HY

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-27

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no declaration of interest.

Auteurs

M Graille (M)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Route de la Corniche 2, 1066 Epalinges-Lausanne, Switzerland. Electronic address: MelanieGraille@hotmail.com.

P Wild (P)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Route de la Corniche 2, 1066 Epalinges-Lausanne, Switzerland; Institut national de recherche et de sécurité (INRS), Vandoeuvre-lès-Nancy, France. Electronic address: Pascal.Wild@inrs.fr.

J-J Sauvain (JJ)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Route de la Corniche 2, 1066 Epalinges-Lausanne, Switzerland. Electronic address: jean-jacques.sauvain@unisante.ch.

M Hemmendinger (M)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Route de la Corniche 2, 1066 Epalinges-Lausanne, Switzerland. Electronic address: maud.hemmendinger@unisante.ch.

I Guseva Canu (I)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Route de la Corniche 2, 1066 Epalinges-Lausanne, Switzerland. Electronic address: irina.guseva-canu@unisante.ch.

N B Hopf (NB)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Route de la Corniche 2, 1066 Epalinges-Lausanne, Switzerland; Swiss Center for Applied Human Toxicology (SCAHT), Missionsstrasse 64, 4055 Basel, Switzerland. Electronic address: Nancy.Hopf@unisante.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH